SCHEMBL1063161

SCHEMBL1063161

CC1CNC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2366362 1.00
SCHEMBL2366380 1.00
SCHEMBL11550886 0.82 LMNA (0.33)
SCHEMBL7092834 0.77 PDE3B (0.40)
SCHEMBL15879498 0.77 MAPT (0.33)
SCHEMBL3387416 0.75
SCHEMBL30805561 0.72
SCHEMBL16876171 0.72
SCHEMBL16876498 0.72
SCHEMBL30834595 0.70 CA1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 567 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341244-A1 SYNTHESIS OF N-VINYL COMPOUNDS BY REACTING NH-COMPOUNDS WITH ACETYLENE IN PRESENCE OF HOMOGENEOUS PHOSPHINE CATALYST BASF SE (DE) 2024-03-27 EP claimed
CN-117321033-A Synthesis of N-vinyl compounds by reacting NH-compounds with acetylene in the presence of a homogeneous phosphine catalyst 巴斯夫欧洲公司 2023-12-29 CN claimed
WO-2022243097-A1 SYNTHESIS OF N-VINYL COMPOUNDS BY REACTING NH-COMPOUNDS WITH ACETYLENE IN PRESENCE OF HOMOGENEOUS PHOSPHINE CATALYST BASF SE (DE) 2022-11-24 WO claimed
EP-3723807-A1 COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES H. Lundbeck A/S (DK) 2020-10-21 EP claimed
EP-3723808-A1 COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES H. Lundbeck A/S (DK) 2020-10-21 EP claimed
EP-3556354-A1 ORAL PREPARATION OF GLUCOKINASE ACTIVATOR AND PREPARATION METHOD THEREFOR Hua Medicine (Shanghai) Ltd. (CN) 2019-10-23 EP claimed
WO-2019115566-A1 COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES H. LUNDBECK A/S (DK) 2019-06-20 WO claimed
WO-2019115567-A1 COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES H. LUNDBECK A/S (DK) 2019-06-20 WO claimed
EP-3050873-B1 SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN INC (US) 2017-09-13 EP claimed
EP-3050873-A1 SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2016-08-03 EP claimed
EP-0282547-A1 METHOD FOR CONTROLLING EMESIS CAUSED BY CHEMOTHERAPEUTIC AGENTS AND ANTIEMETIC AGENTS USEFUL THEREIN. ADRIA LAB INC (US) 1988-09-21 EP claimed
US-4772597-A ANTIBIOTICS PFIZER INC. (US) 1988-09-20 US claimed
WO-1988001866-A1 METHOD FOR CONTROLLING EMESIS CAUSED BY CHEMOTHERAPEUTIC AGENTS AND ANTIEMETIC AGENTS USEFUL THEREIN ADRIA LABORATORIES, INC. (US) 1988-03-24 WO claimed
US-4521626-A Preparations of alkanolamines THE DOW CHEMICAL COMPANY (US) 1985-06-04 US claimed
EP-0138539-A1 2-Azacycloalkylthiopenem derivatives PFIZER INC. (US) 1985-04-24 EP claimed
US-4465837-A Preparation of 5-methyl-2-oxazolidinones THE DOW CHEMICAL COMPANY (US) 1984-08-14 US claimed
EP-0014976-B1 N-SUBSTITUTED 2-CYANAZIRIDINES, METHODS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM, CORRESPONDINGLY SUBSTITUTED AZIRIDINE-2-CARBONAMIDES AND THEIR PREPARATION Roche Diagnostics GmbH (DE) 1982-04-07 EP claimed
EP-0037141-A1 Purification of cyanuric acid FMC Corporation (US) 1981-10-07 EP claimed
US-4282359-A MECHANICAL SEPARATION FROM HEATED SLURRY CONTAINING UREA ANOR BIURET FMC CORPORATION (US) 1981-08-04 US claimed
US-3994892-A SUSPENSION STAMICARBON B.V. (NL) 1976-11-30 US claimed